课题基金 / 基金详情

项目摘要

项目成果

Harry T. Orr的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Spinocerebellar ataxia type 1 (SCA1) is an untreatable fatal autosomal dominant neurodegenerative disorder caused by the expansion of a glutamine repeat within the SCA1-encoded protein ATXN1. Previous work showed that ATXN1 is modified by phosphorylation at serine residue 776 and this phosphorylation is critical for mutant ATXN1 to cause disease. Recent evidence form the parent project indicates that PKA mediates the phosphorylation of serine 776. This application, in response to Notice Number (NOT-OD-09-058), "NIH Announces the Availability of Recovery Act Funds for Competitive Revisions Applications" is a request to undertake a high-throughput screen and lead compound optimization for inhibitors of PKA-mediated phosphorylation of serine 776.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular genetics of neurodegenerative pathogenic and protective pathways: The SCA1 perspective
  • 批准号:
    10450471
  • 项目类别:
  • 资助金额:
    $53.43万
  • 财政年份:
    2022
  • 负责人:
    Harry T. Orr
  • 依托单位:
Molecular genetics of neurodegenerative pathogenic and protective pathways: The SCA1 perspective
  • 批准号:
    10614029
  • 项目类别:
  • 资助金额:
    $84.87万
  • 财政年份:
    2022
  • 负责人:
    Harry T. Orr
  • 依托单位:
Molecular Genetics of SCA1
  • 批准号:
    9072268
  • 项目类别:
  • 资助金额:
    $19.96万
  • 财政年份:
    2015
  • 负责人:
    Harry T. Orr
  • 依托单位:
AIM 2014 Conference
  • 批准号:
    8650554
  • 项目类别:
  • 资助金额:
    $2.0万
  • 财政年份:
    2013
  • 负责人:
    Harry T. Orr
  • 依托单位:
海外基金